dQM QICore Content Implementation Guide
2025.0.0 - CI Build
dQM QICore Content Implementation Guide, published by cqframework. This guide is not an authorized publication; it is the continuous build for version 2025.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cqframework/dqm-content-qicore-2025/ and changes regularly. See the Directory of published versions
Official URL: https://madie.cms.gov/Measure/CMS771FHIRUrinarySymptomScoreBPH | Version: 1.0.000 | |||
Active as of 2025-08-22 | Responsible: Large Urology Group Practice Association (LUGPA) | Computable Name: CMS771FHIRUrinarySymptomScoreBPH | ||
Other Identifiers: Short Name: CMS771FHIR (use: usual, ), UUID:0748d873-8e20-441e-9bbf-c1eefe3ea054 (use: official, ), UUID:1765122b-5409-43cb-9449-3d1a62a8ea78 (use: official, ), Publisher: 771FHIR (use: official, ) | ||||
Copyright/Legal: Limited proprietary coding is contained in the measure specifications for user convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. Large Urology Group Practice Association (LUGPA) and Oregon Urology Institute (OUI) disclaim all liability for the use or accuracy of any third-party codes contained in the specifications. CPT(R) contained in the Measure specifications is copyright 2004-2024. American Medical Association. LOINC(R) copyright 2004-2024 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2024 International Health Terminology Standards Development Organisation. ICD-10 copyright 2024 World Health Organization. All Rights Reserved. |
Percentage of patients with an office visit within the measurement period and with a new diagnosis of clinically significant Benign Prostatic Hyperplasia who have International Prostate Symptoms Score (IPSS) or American Urological Association (AUA) Symptom Index (SI) documented at time of diagnosis and again 6-12 months later with an improvement of 3 points
Metadata | |
---|---|
Title | Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic HyperplasiaFHIR |
Version | 1.0.000 |
Short Name | CMS771FHIR |
GUID (Version Independent) | urn:uuid:0748d873-8e20-441e-9bbf-c1eefe3ea054 |
GUID (Version Specific) | urn:uuid:1765122b-5409-43cb-9449-3d1a62a8ea78 |
CMS Identifier | 771FHIR |
Effective Period | 2026-01-01 through 2026-12-31 |
Steward (Publisher) | Large Urology Group Practice Association (LUGPA) |
Developer | Large Urology Group Practice Association (LUGPA) |
Description | Percentage of patients with an office visit within the measurement period and with a new diagnosis of clinically significant Benign Prostatic Hyperplasia who have International Prostate Symptoms Score (IPSS) or American Urological Association (AUA) Symptom Index (SI) documented at time of diagnosis and again 6-12 months later with an improvement of 3 points |
Copyright | Limited proprietary coding is contained in the measure specifications for user convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. Large Urology Group Practice Association (LUGPA) and Oregon Urology Institute (OUI) disclaim all liability for the use or accuracy of any third-party codes contained in the specifications. CPT(R) contained in the Measure specifications is copyright 2004-2024. American Medical Association. LOINC(R) copyright 2004-2024 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2024 International Health Terminology Standards Development Organisation. ICD-10 copyright 2024 World Health Organization. All Rights Reserved. |
Disclaimer | The performance measure is not a clinical guideline and does not establish a standard of medical care, and has not been tested for all potential applications. THE MEASURE AND SPECIFICATIONS ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND. Due to technical limitations, registered trademarks are indicated by (R) or [R], and unregistered trademarks are indicated by (TM) or [TM]. |
Rationale | Benign prostatic hyperplasia (BPH) is one of the most common conditions affecting older males, with a prevalence of 50% by age 60 years and 90% by the ninth decade of life (Medina et al., 1999). The enlarged gland had been proposed to contribute to the overall lower urinary tract symptoms (LUTS) complex (McVary et al., 2014). Although LUTS secondary to BPH is not often a life-threatening condition, the impact of LUTS/BPH on quality of life can be significant (Wei et al., 2005). The American Urological Association Symptom Index (AUA-SI) and the International Prostate Symptom Score (IPSS) were developed to measure outcomes in studies of different treatments for BPH (Wuerstle et al., 2011). The IPSS uses the same questions as the AUA-SI, but also adds a disease-specific Quality of Life (QOL) score question (O'Leary, 2005). The IPSS was adopted in 1993 by the World Health Organization. It is a reproducible, validated index designed to determine disease severity and response to therapy (D’Silva et al., 2014). It includes 3 storage symptom questions (frequency, nocturia, urgency) and four voiding symptoms (feeling of incomplete emptying, intermittency, straining, and a weak stream) as well as a Bother question: If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that? A three-point improvement in the score is considered meaningful (McVary et al., 2014). |
Clinical Recommendation Statement | The symptoms of BPH are lower urinary tract symptoms (LUTS). There are other disorders with similar symptoms that need to be excluded. History, physical examination, and testing are required prior to a diagnosis of BPH. IPSS by itself is not a reliable diagnostic tool for LUTS suggestive of BPH but serves as a quantitative measure of LUTS after the diagnosis is established (D’Silva et al., 2014). Medical and surgical interventions for BPH recommend a follow up IPSS evaluation to determine effectiveness of treatment. IPSS should be evaluated at the time of diagnosis and after definitive treatment. |
Citation |
D'Silva, K. A., Dahm, P., & Wong, C. L. (2014). Does this man with lower urinary tract symptoms have bladder outlet obstruction? The Rational Clinical Examination: A systematic review. Journal of the American Medical Association, 312(5), 535-542. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/25096693 |
Citation |
McVary, K. T., Roehrborn, C. G., Avins, A. L., et al. (2014). Management of benign prostatic hyperplasia. Retrieved from https://pubmed.ncbi.nlm.nih.gov/21420124/ |
Citation |
Medina, J. J., Parra, R. O., & Moore, R. G. (1999). Benign prostatic hyperplasia (the aging prostate). Medical Clinics of North America, 83(5), 1213-1229. Retrieved from http://www.sciencedirect.com/science/article/pii/S0025712505701590 |
Citation |
O'Leary, M. P. (2005). Validity of the Bother Score in the evaluation and treatment of symptomatic benign prostatic hyperplasia. Reviews in Urology, 7(1), 1-10. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1477553/ |
Citation |
Wei, J., Calhoun, E., & Jacobsen, S. (2005). Urologic diseases in America project: Benign prostatic hyperplasia. Journal of Urology, 173(4), 1256-1261. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/15758764 |
Citation |
Wuerstle, M. C., Van Den Eeden, S. K., Poon, K. T., et al. (2011). Contribution of common medications to lower urinary tract symptoms in men. Archives of Internal Medicine, 171(18), 1680-1682. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/21987200 |
Definition | Clinically Significant Benign Prostatic Hyperplasia (BPH) : BPH with lower urinary tract symptoms (LUTS) |
Guidance (Usage) | The IPSS is inclusive of the symptom index score and the Quality of Life (QOL) score. The AUA-SI is the symptom index score alone and must be added to the QOL score. The AUA-SI with the QOL equals the IPSS. Both of these are the urinary symptom score. The patient must have a urinary symptom score (USS) within 1 month after initial diagnosis. If more than one USS in the initial one month, then the first USS counts. The patient must have a USS again at 6-12 months after the initial diagnosis and if more than one USS in this time frame, then the last USS counts. The result of the test is a numeric value that relates to a continuous numeric scale. Reported either as an integer, a ratio, a real number, or a range. The test result value may optionally contain a relational operator from the set {<=, <, >, >=}. Valid values for a quantitative test are of the form “7”, “-7”, “7.4”, “-7.4”, “7.8912”, “0.125”, “<10”, “<10.15”, “>12000”, 1-10, 1:256. Hospitalization within 30 days of Initial BPH Diagnosis refers to a 30-day period between the end of the hospitalization and the clinical office setting BPH diagnosis. This is due to aggravating factors from hospitalization, such as bed rest, medications, surgery, and altered body functions. Symptoms of BPH include urinary frequency, urinary urgency, difficulty starting urination, weak urine stream, dribbling at the end of urination, incomplete bladder emptying. This eCQM is a patient-based measure. Telehealth encounters are not eligible for this measure because the measure requires a clinical action that cannot be conducted via telehealth. This FHIR-based measure has been derived from the QDM-based measure CMS771v7. Please refer to the HL7 QI-Core Implementation Guide (https://hl7.org/fhir/us/qicore/STU6/) for more information on QI-Core and mapping recommendations from QDM to QI-Core STU 6 (https://hl7.org/fhir/us/qicore/STU6/qdm-to-qicore.html). |
Measure Group (Rate) (ID: Group_1) | |
Basis | boolean |
Scoring | [http://terminology.hl7.org/CodeSystem/measure-scoring#proportion: 'Proportion'] |
Type | [http://terminology.hl7.org/CodeSystem/measure-type#outcome: 'Outcome'] |
Rate Aggregation | None |
Improvement Notation | [http://terminology.hl7.org/CodeSystem/measure-improvement-notation#increase: 'Increased score indicates improvement'] |
Initial Population |
ID: InitialPopulation_1
Description: Male patients with an initial diagnosis of benign prostatic hyperplasia 6 months prior to the measurement period who had a qualifying visit during the measurement period Logic Definition: Initial Population |
Denominator |
ID: Denominator_1
Description: Patients in the Initial Population with a urinary symptom score assessment within 1 month of initial diagnosis and a follow-up urinary symptom score assessment within 6-12 months Logic Definition: Denominator |
Denominator Exclusion |
ID: DenominatorExclusion_1
Description: Patients with urinary retention that starts within 1 year of initial BPH diagnosis. Patients with an initial BPH diagnosis that starts during, or within 30 days after end of hospitalization. Patients with a diagnosis of morbid obesity, or with a BMI Exam >=40 before the follow up urinary symptom score. Logic Definition: Denominator Exclusions |
Numerator |
ID: Numerator_1
Description: Patients with a documented improvement of at least 3 points in their urinary symptom score during the measurement period Logic Definition: Numerator |
Supplemental Data Guidance | For every patient evaluated by this measure also identify payer, race, ethnicity and sex |
Supplemental Data Elements | |
Supplemental Data Element |
ID: sde-ethnicity
Usage Code: [http://terminology.hl7.org/CodeSystem/measure-data-usage#supplemental-data] Description: SDE Ethnicity Logic Definition: SDE Ethnicity |
Supplemental Data Element |
ID: sde-payer
Usage Code: [http://terminology.hl7.org/CodeSystem/measure-data-usage#supplemental-data] Description: SDE Payer Logic Definition: SDE Payer |
Supplemental Data Element |
ID: sde-race
Usage Code: [http://terminology.hl7.org/CodeSystem/measure-data-usage#supplemental-data] Description: SDE Race Logic Definition: SDE Race |
Supplemental Data Element |
ID: sde-sex
Usage Code: [http://terminology.hl7.org/CodeSystem/measure-data-usage#supplemental-data] Description: SDE Sex Logic Definition: SDE Sex |
Measure Logic | |
Primary Library | https://madie.cms.gov/Library/CMS771FHIRUrinarySymptomScoreBPH |
Contents |
Population Criteria
Logic Definitions Terminology Dependencies Data Requirements |
Population Criteria | |
Measure Group (Rate) (ID: Group_1) | |
Initial Population | |
|
|
Denominator | |
|
|
Denominator Exclusion | |
|
|
Numerator | |
|
|
Logic Definitions | |
Logic Definition | Library Name: SupplementalDataElements |
|
|
Logic Definition | Library Name: SupplementalDataElements |
|
|
Logic Definition | Library Name: SupplementalDataElements |
|
|
Logic Definition | Library Name: SupplementalDataElements |
|
|
Logic Definition | Library Name: CMS771FHIRUrinarySymptomScoreBPH |
|
|
Logic Definition | Library Name: CMS771FHIRUrinarySymptomScoreBPH |
|
|
Logic Definition | Library Name: CMS771FHIRUrinarySymptomScoreBPH |
|
|
Logic Definition | Library Name: CMS771FHIRUrinarySymptomScoreBPH |
|
|
Logic Definition | Library Name: CMS771FHIRUrinarySymptomScoreBPH |
|
|
Logic Definition | Library Name: CMS771FHIRUrinarySymptomScoreBPH |
|
|
Logic Definition | Library Name: CMS771FHIRUrinarySymptomScoreBPH |
|
|
Logic Definition | Library Name: CMS771FHIRUrinarySymptomScoreBPH |
|
|
Logic Definition | Library Name: CMS771FHIRUrinarySymptomScoreBPH |
|
|
Logic Definition | Library Name: CMS771FHIRUrinarySymptomScoreBPH |
|
|
Logic Definition | Library Name: CMS771FHIRUrinarySymptomScoreBPH |
|
|
Logic Definition | Library Name: CMS771FHIRUrinarySymptomScoreBPH |
|
|
Logic Definition | Library Name: CMS771FHIRUrinarySymptomScoreBPH |
|
|
Logic Definition | Library Name: CMS771FHIRUrinarySymptomScoreBPH |
|
|
Logic Definition | Library Name: CMS771FHIRUrinarySymptomScoreBPH |
|
|
Logic Definition | Library Name: CMS771FHIRUrinarySymptomScoreBPH |
|
|
Logic Definition | Library Name: CMS771FHIRUrinarySymptomScoreBPH |
|
|
Logic Definition | Library Name: CMS771FHIRUrinarySymptomScoreBPH |
|
|
Logic Definition | Library Name: CMS771FHIRUrinarySymptomScoreBPH |
|
|
Logic Definition | Library Name: CMS771FHIRUrinarySymptomScoreBPH |
|
|
Logic Definition | Library Name: CMS771FHIRUrinarySymptomScoreBPH |
|
|
Logic Definition | Library Name: CMS771FHIRUrinarySymptomScoreBPH |
|
|
Logic Definition | Library Name: CMS771FHIRUrinarySymptomScoreBPH |
|
|
Logic Definition | Library Name: CMS771FHIRUrinarySymptomScoreBPH |
|
|
Logic Definition | Library Name: QICoreCommon |
|
|
Logic Definition | Library Name: QICoreCommon |
|
|
Logic Definition | Library Name: FHIRHelpers |
|
|
Logic Definition | Library Name: FHIRHelpers |
|
|
Logic Definition | Library Name: FHIRHelpers |
|
|
Terminology | |
Code System |
Description: Code system SNOMEDCT
Resource: http://snomed.info/sct Canonical URL: http://snomed.info/sct |
Code System |
Description: Code system LOINC
Resource: http://loinc.org Canonical URL: http://loinc.org |
Code System |
Description: Code system ICD10CM
Resource: http://hl7.org/fhir/sid/icd-10-cm Canonical URL: http://hl7.org/fhir/sid/icd-10-cm |
Code System |
Description: Code system ActCode
Resource: http://terminology.hl7.org/CodeSystem/v3-ActCode Canonical URL: http://terminology.hl7.org/CodeSystem/v3-ActCode |
Value Set |
Description: Value set Office Visit
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1001 Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1001 |
Value Set |
Description: Value set Payer Type
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591 Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591 |
Value Set |
Description: Value set Urinary Retention
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.372 Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.372 |
Value Set |
Description: Value set Hospital Services for Urology Care
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.360 Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.360 |
Value Set |
Description: Value set Morbid Obesity
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.368 Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.368 |
Direct Reference Code |
Display: Male (finding)
Code: 248153007 System: http://snomed.info/sct |
Direct Reference Code |
Display: Female (finding)
Code: 248152002 System: http://snomed.info/sct |
Direct Reference Code |
Display: International Prostate Symptom Score [IPSS]
Code: 80976-4 System: http://loinc.org |
Direct Reference Code |
Display: American Urological Association Symptom Index [AUASI]
Code: 80883-2 System: http://loinc.org |
Direct Reference Code |
Display: If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that [IPSS]
Code: 81090-3 System: http://loinc.org |
Direct Reference Code |
Display: Benign prostatic hyperplasia with lower urinary tract symptoms
Code: N40.1 System: http://hl7.org/fhir/sid/icd-10-cm |
Direct Reference Code |
Display: virtual
Code: VR System: http://terminology.hl7.org/CodeSystem/v3-ActCode |
Dependencies | |
Dependency |
Description: QICore model information
Resource: http://hl7.org/fhir/Library/QICore-ModelInfo Canonical URL: http://hl7.org/fhir/Library/QICore-ModelInfo |
Dependency |
Description: Library SDE
Resource: https://madie.cms.gov/Library/SupplementalDataElements|5.1.000 Canonical URL: https://madie.cms.gov/Library/SupplementalDataElements|5.1.000 |
Dependency |
Description: Library FHIRHelpers
Resource: https://madie.cms.gov/Library/FHIRHelpers|4.4.000 Canonical URL: https://madie.cms.gov/Library/FHIRHelpers|4.4.000 |
Dependency |
Description: Library QICoreCommon
Resource: https://madie.cms.gov/Library/QICoreCommon|4.0.000 Canonical URL: https://madie.cms.gov/Library/QICoreCommon|4.0.000 |
Data Requirements | |
Data Requirement |
Type: Patient
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient Must Support Elements: extension, url |
Data Requirement |
Type: Observation
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation-screening-assessment Must Support Elements: code, effective, status, status.value, value Code Filter(s): Path: code Code(s): http://loinc.org#80883-2: 'American Urological Association Symptom Index [AUASI]' |
Data Requirement |
Type: Observation
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation-screening-assessment Must Support Elements: code, effective, status, status.value, value Code Filter(s): Path: code Code(s): http://loinc.org#81090-3: 'If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that [IPSS]' |
Data Requirement |
Type: Observation
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation-screening-assessment Must Support Elements: code, status, status.value, value, effective Code Filter(s): Path: code Code(s): http://loinc.org#80976-4: 'International Prostate Symptom Score [IPSS]' |
Data Requirement |
Type: Condition
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-problems-health-concerns Must Support Elements: code Code Filter(s): Path: code Code(s): http://hl7.org/fhir/sid/icd-10-cm#N40.1: 'Benign prostatic hyperplasia with lower urinary tract symptoms' |
Data Requirement |
Type: Condition
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-problems-health-concerns Must Support Elements: code Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.372 |
Data Requirement |
Type: Condition
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-problems-health-concerns Must Support Elements: code Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.368 |
Data Requirement |
Type: Condition
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-encounter-diagnosis Must Support Elements: code Code Filter(s): Path: code Code(s): http://hl7.org/fhir/sid/icd-10-cm#N40.1: 'Benign prostatic hyperplasia with lower urinary tract symptoms' |
Data Requirement |
Type: Condition
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-encounter-diagnosis Must Support Elements: code Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.372 |
Data Requirement |
Type: Condition
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-encounter-diagnosis Must Support Elements: code Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.368 |
Data Requirement |
Type: Encounter
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-encounter Must Support Elements: type, period, class, status, status.value Code Filter(s): Path: type ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1001 |
Data Requirement |
Type: Encounter
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-encounter Must Support Elements: type, period, status, status.value Code Filter(s): Path: type ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.360 |
Data Requirement |
Type: Coverage
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-coverage Must Support Elements: type, period Code Filter(s): Path: type ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591 |
Data Requirement |
Type: Observation
Profile(s): http://hl7.org/fhir/us/core/StructureDefinition/us-core-bmi Must Support Elements: value, status, status.value, effective |
Generated using version 0.4.8 of the sample-content-ig Liquid templates |